PPA
GSK icon

Parametric Portfolio Associates’s GSK GSK Stock Holding History

Parametric Portfolio Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$122M Buy
2,242,426
+76,403
+4% +$4.15M 0.06% 291
2021
Q4 		$119M Buy
2,166,023
+249,813
+13% +$13M 0.06% 301
2021
Q3 		$91.5M Buy
1,916,210
+138,492
+8% +$6.96M 0.05% 341
2021
Q2 		$88.5M Buy
1,777,718
+295,086
+20% +$14.2M 0.05% 366
2021
Q1 		$66.1M Buy
1,482,632
+15,154
+1% +$688K 0.04% 470
2020
Q4 		$67.5M Sell
1,467,478
-449,247
-23% -$20.6M 0.04% 401
2020
Q3 		$90.2M Sell
1,916,725
-88,804
-4% -$4.45M 0.06% 266
2020
Q2 		$102M Sell
2,005,529
-180,087
-8% -$9.24M 0.08% 220
2020
Q1 		$104M Sell
2,185,616
-115,799
-5% -$6.18M 0.09% 192
2019
Q4 		$135M Buy
2,301,415
+112,010
+5% +$6.23M 0.1% 190
2019
Q3 		$117M Buy
2,189,405
+60,958
+3% +$3.14M 0.09% 203
2019
Q2 		$106M Sell
2,128,447
-83,753
-4% -$4.2M 0.09% 218
2019
Q1 		$116M Buy
2,212,200
+86,170
+4% +$4.31M 0.1% 187
2018
Q4 		$102M Buy
2,126,030
+6,717
+0.3% +$331K 0.1% 188
2018
Q3 		$106M Buy
2,119,313
+165,427
+8% +$8.4M 0.09% 201
2018
Q2 		$98.5M Buy
1,953,886
+160,912
+9% +$8.1M 0.09% 209
2018
Q1 		$87.6M Buy
1,792,974
+871,875
+95% +$40.6M 0.09% 223
2017
Q4 		$40.8M Sell
921,099
-240,875
-21% -$11.1M 0.04% 444
2017
Q3 		$59M Buy
1,161,974
+73,700
+7% +$3.74M 0.06% 305
2017
Q2 		$58.7M Buy
1,088,274
+148,933
+16% +$7.94M 0.07% 281
2017
Q1 		$49.5M Buy
939,341
+132,751
+16% +$6.73M 0.08% 243
2016
Q4 		$38.8M Sell
806,590
-95,765
-11% -$4.73M 0.05% 347
2016
Q3 		$48.6M Buy
902,355
+23,005
+3% +$1.26M 0.07% 282
2016
Q2 		$47.6M Sell
879,350
-21,436
-2% -$1.13M 0.08% 265
2016
Q1 		$45.7M Buy
900,786
+137,941
+18% +$6.87M 0.07% 262
2015
Q4 		$38.5M Buy
762,845
+29,293
+4% +$1.49M 0.07% 305
2015
Q3 		$35.3M Buy
733,552
+38,360
+6% +$2M 0.07% 301
2015
Q2 		$36.2M Buy
695,192
+22,394
+3% +$1.26M 0.07% 272
2015
Q1 		$38.8M Buy
672,798
+96,944
+17% +$5.56M 0.08% 263
2014
Q4 		$30.8M Buy
575,854
+136,000
+31% +$7.61M 0.06% 317
2014
Q3 		$25.3M Sell
439,854
-18,497
-4% -$1.13M 0.06% 357
2014
Q2 		$30.6M Buy
458,351
+26,656
+6% +$1.8M 0.07% 293
2014
Q1 		$28.8M Buy
431,695
+5,761
+1% +$389K 0.07% 306
2013
Q4 		$28.4M Buy
425,934
+44,699
+12% +$2.9M 0.07% 305
2013
Q3 		$23.9M Buy
381,235
+18,771
+5% +$1.21M 0.06% 325
2013
Q2 		$22.6M Buy
+362,464
New +$23M 0.07% 319

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Parametric Portfolio Associates's GSK Position: Q1 2022 in Review

Parametric Portfolio Associates increased its GSK (GSK) stake by 3.5% in Q1 2022, buying an estimated $4.15M and bringing the position to 2,242,426 shares worth $122M. The position accounts for 0.06% of the portfolio, ranked #291.

Parametric Portfolio Associates first reported a position in GSK in Q2 2013 and has held it in 36 quarters since. The position peaked at $135M in Q4 2019. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • Parametric Portfolio Associates held 2,242,426 shares of GSK worth $122M as of Q1 2022.
  • Parametric Portfolio Associates bought 76,403 GSK shares in Q1 2022, an estimated $4.15M.
  • GSK made up 0.06% of Parametric Portfolio Associates's portfolio in Q1 2022, its #291 holding.
  • Parametric Portfolio Associates first reported a position in GSK in Q2 2013 and has held it in 36 quarters since.
  • Parametric Portfolio Associates's GSK position peaked at $135M in Q4 2019.
  • 929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.